Zimmer Biomet Holdings Inc. EO-Notes 2016(16/26) Anleihe

 

Zimmer Biomet plans to acquire Monogram and integrate its robotic knee system into its ROSA platform to support growth and product expansion through 2027. read more...

WASHINGTON (dpa-AFX) - Medical technology company Zimmer Biomet Holdings, Inc. (ZBH), and Monogram Technologies Inc. (MGRM), an orthopedic robotics company, announced Monday they have entered into......

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

Zimmer Biomet Announces Definitive Agreement to Acquire Monogram Technologies, Expanding Robotics Suite with Autonomous Solutions...

Regenerative medicine company Osteopore (ASX: OSX) has secured market approval in Switzerland for its off-the-shelf and custom-made biomimetic and bioresorbable implants. Approval came under the European Union's medical device regulations (MDR) and follows the company's partnership with US orthopaedic solutions company Zimmer Biomet to distribute its craniofacial products in Europe, the Middle East and Africa, the […] The post Osteopore Granted Swiss Market Approval for Custom Bioresorbable Implants appeared first on Small Caps....

GOTHENBURG, SWEDEN AND WARSAW, IND. – July 10, 2025 – Global MedTech companies Getinge and Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), today announced a strategic partnership where Zimmer Biomet will distribute Getinge's Operating Room (OR) capital products to its Ambulatory Surgery Center (ASC) customers. This partnership creates a turnkey solution for ASC customers, who can now access Getinge's infection control and surgical portfolio and Zimmer Biomet's broad menu of best-in-class implants and surgical robotics from a single source. [image] ASCs are modern healthcare facilities...

WARSAW, Ind., July 9, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its second quarter earnings conference call will be webcast on Thursday, August 7, 2025 at 8:30 a.m. ET. A news release detailing the quarterly results will be made available that......

Das Instrument ZIM US98956P1021 ZIMMER BIOMET HLDGS DL-01 EQUITY wird ex Dividende/Zinsen gehandelt am 26.06.2025 The instrument ZIM US98956P1021 ZIMMER BIOMET HLDGS DL-01 EQUITY has its ex-dividend/interest day on 26.06.2025...

Yi, Sang - Vorstand - Tag der Transaktion: 2025-06-13...

Zimmer Biomet has underperformed the Nasdaq over the past year, but analysts are cautiously optimistic about the stock's prospects....

Yi, Sang - Vorstand - Tag der Transaktion: 2025-06-11...

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

PONTE VEDRA, Fla., June 05, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship Lapiplasty® and Adductoplasty® procedures, today announced that it filed a lawsuit against Zimmer Biomet Holdings, Inc. and Paragon 28, Inc. (collectively, “Zimmer”) (NYSE: ZBH), alleging infringement of 4 patents related to Treace's innovative Lapiplasty® 3D Bunion Correction® technologies. The suit was filed in the United States District Court for the District of Delaware, and seeks injunctive relief and damages....

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

WARSAW, Ind., May 30, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the second quarter of 2025. The cash......

ROSEMONT, Ill., May 29, 2025 /PRNewswire/ -- The Orthopaedic Research and Education Foundation (OREF), the leading private nonprofit organization funding musculoskeletal (MSK) research across all orthopaedic sub-specialties, is pleased to announce that Ivan Tornos, Chairman, President and......

WARSAW, Ind., May 27, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced the appointment of Kevin Thornal as Group President, Global Businesses and the Americas. Reporting to Chairman-Elect, President and CEO Ivan......

WARSAW, Ind., May 22, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced that members of the Zimmer Biomet management team will be presenting at the Goldman Sachs 46th Annual Global Healthcare Conference on Monday, June 9, 2025, at 9:20 a.m. ET. A live......

Zimmer Biomet is strategically expanding its global presence to address the huge demand in the musculoskeletal space....

Zimmer Biomet has underperformed the broader market over the past year, but analysts are moderately optimistic about the stock's prospects....